Biotech China 2014

Leukemia: Harvard University

Total Score People Score Events Score
122 101 21
Date Event Presentation Speakers
May 31, 2013 ASCO Annual Meeting 2013 Optimizing the Role of Advanced Practice Professionals in Oncology Practice Lawrence N. Shulman
Hot Pathways for Targeted Therapy of B-Cell Malignancies James E. Bradner
Beyond Trastuzumab and Lapatinib: New Options for HER2-Positive Breast Cancer Ian E. Krop
Clinical Management, Molecular Alterations, and Future Perspectives in Urothelial Cancer David Kwiatkowski
Cancer Stem Cells: A New and Better Target in Pediatric Oncology? Scott A. Armstrong, George Daley
Reaping the Rewards of the Cancer Genome Atlas Project Levi A Garraway
Improving Cancer Care through Health Information Technology: Ethics and Practicality Lawrence N. Shulman
Education Sessions Robert G Maki, Stephen T Sonis
Education Sessions Deborah Schrag
Education Sessions Tracy T Batchelor
Education Sessions Michael B. Atkins, Jennifer A. Ligibel
Educations Sessions Monica M. Bertagnolli
Education Sessions Bruce E. Johnson, Elizabeth R. Gerstner
April 6, 2013 AACR Annual Meetings EPIGENETIC TARGETS FOR CANCER Anjana Rao, James E. Bradner
Developmental Origins of Cancer Chairperson: Richard J. Gilbertson, St. Jude Children's Research Hospital, Memphis, TN Stuart H. Orkin
Blood-Based Molecular Analysis of Cancer Daniel A Haber
Intrinsic and Microenvironment-Dependent Adaptive Responses that Regulate Drug Resistance Chairperson: Joan S. Brugge, Harvard Medical School, Boston, MA Joan S Brugge
The Interface Between Development and Cancer Using Model Organisms Chairperson: Michael M. Shen, Columbia University, New York, NY Leonard I. Zon
Emerging Single Cell Technologies in Cancer Research Chairperson: Garry P. Nolan, Stanford University School of Medicine, Stanford, CA Claude Lechene
Mutations in Epigenetic Regulators in Cancer Chairperson: Scott A. Armstrong, Memorial Sloan-Kettering Cancer Center, New York, NY Scott A. Armstrong
Mitotic Checkpoints Driving Cancer Therapeutic Strategies Chairperson: Peter K. Jackson, Genentech, Inc., South San Francisco, CA Timothy J Mitchison
Translational Control and Stress Response Pathways in Cancer Chairperson: Davide Ruggero, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA Karen Cichowski
Developmental and Molecular Origins of Brain Tumors Co-Chairpersons: Suzanne J. Baker, St. Jude Children's Research Hospital, Memphis, TN, and Cameron W. Brennan, Memorial Sloan-Kettering Cancer Center, New York, NY Cameron W Brennan
Synthetic Lethality and Genetic Approaches to Cancer Chairperson: Stephen J. Elledge, Harvard Medical School, Boston, MA Stephen J Elledge
Structural Aberrations in a Thousand Tumors Chairperson: Raju Kucherlapati, Harvard Medical School, Boston, MA Raju Kucherlapati
The Stanley J. Korsmeyer Memorial Symposium: Targeting Cell Death Pathways for Cancer Therapy Chairperson: Anthony G. Letai, Dana-Farber Cancer Institute, Boston, MA Anthony G. Letai
The Origins and Clinical Implications of Precancerous Lesions Chairperson: Cory Abate-Shen, Columbia University Irving Comprehensive Cancer Center, New York, NY Kornelia Polyak
Noncoding RNAs and Cancer Chairperson: Phillip A. Sharp, David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA Jeannie T. Lee
New Cancer Vaccines Chairperson: Glenn Dranoff, Dana-Farber Cancer Institute, Boston, MA Glenn Dranoff
The Origins and Neoplastic Progression of Barrett's Esophagus Co-Chairpersons: Timothy C. Wang, Columbia University Medical Center, New York, NY, and Brian J. Reid, Fred Hutchinson Cancer Research Center, Seattle, WA Frank McKeon
Molecular Basis and Therapeutic Targeting of Bone Metastasis Co-Chairpersons: Yibin Kang, Princeton University, Princeton, NJ, and Matthew R. Smith, Massachusetts General Hospital Cancer Center, Boston, MA Matthew Smith
Molecular and Cellular Determinants of Brain Metastasis Co-Chairpersons: William C. Hahn, Dana-Farber Cancer Institute, Boston, MA, and Joan Massagué, Memorial Sloan-Kettering Cancer Center, New York, NY Rakesh K Jain, William C Hahn
Avatar: Individualized Human Cancer Models in Mice Kwok-Kin Wong
Next-Generation Therapeutic Modeling in Mice Pier Paolo
The Utility of Cancer Cell Line Screens for Modeling Drug Sensitivities Moderator: Jeffrey Settleman, Genentech, Inc., South San Francisco, CA Levi A Garraway
Clinical Trials Based on Mutations versus Histology William R Sellers, Lewis C Cantley
Human Papillomavirus: Beyond Cervical Cancer Chairperson: Maura L. Gillison, The Ohio State University Comprehensive Cancer Center, Columbus, OH Peter M Howley
From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 1: Targeting Mechanisms of Therapeutic Resistance Chairperson: Matt V. Lorenzi, Janssen Research & Development, Spring House, PA Kwok-Kin Wong
Credentialing Response Biomarkers for Signal Transduction Inhibitors Chairperson: Neal Rosen, Memorial Sloan-Kettering Cancer Center, New York, NY Anthony G. Letai
Therapeutic Nanotechnology Chairperson: Gregory Lanza, Washington University, St. Louis, MO Omid C Farokhzad
Rational Combination Therapies in Cancer Chairperson: Gordon B. Mills, The University of Texas MD Anderson Cancer Center, Houston, TX Scott A. Armstrong
The Next Frontier in Targeted Therapy for Melanoma Chairperson to be announced Lynda Chin
New Paradigms in Molecular Pharmacology Chairperson: Angela N. Koehler, Broad Institute of MIT and Harvard, Cambridge, MA James E. Bradner
Metabolism and Signaling in Cancer Chairperson: Eyal Gottlieb, The Beatson Institute for Cancer Research, Glasgow, United Kingdom Nika N. Danial
Immune Modulation in the Tumor Microenviroment Chairperson: James P. Allison, Memorial Sloan-Kettering Cancer Center, New York, NY Raghu Kalluri
Cancer Imaging in Mice and Men Andrew L. Kung, Dana-Farber Cancer Institute, Boston, MA Andrew Kung
2-Oxoglutarate-Dependent Dioxygenases as Targets of Cancer-Causing Mutations and Cancer Therapeutics William G. Kaelin, Jr., Dana-Farber Cancer Institute, Boston, MA William G Kaelin
Tumor-Secreted Factors Chairperson: David C. Lyden, Weill Cornell Medical College of Cornell University, New York, NY Xandra O Breakefield
Autocrine Activation of MET and Strategies to Overcome Adaptation for the Targeted Therapy of Acute Myeloid Leukemia A. Thomas Look, Dana-Farber Cancer Institute, Boston, MA Thomas A. Look
Stapled Peptides as Next-Generation Therapeutics Gregory L. Verdine, Harvard University, Cambridge, MA Gregory L Verdine
Prognostic and Predictive Biomarkers of Triple-Negative Breast Cancer Andrea L. Richardson, Brigham and Women's Hospital, Boston, MA Andrea L Richardson
Cancer Omics Beyond the Genome Sunney Xie
16th Annual Grant Writing Workshop Building Presence and Leadership through Empowered Communication Co-Chairpersons: Martine J. Piccart, Institut Jules Bordet, Brussels, Belgium, and Victoria M. Richon. Epizyme, Inc., Wellesley Hills, MA Kornelia Polyak
Patient-Derived Xenograft Models of Cancer: Where Are We Going? Chairperson: Matthew J. Ellis, Washington University Siteman Cancer Center, St. Louis, MO Tan Ince
WICR Career Mentoring Session Joan S Brugge
December 8, 2012 54th American Society of Haematology Annual Meeting and Exposition Regenerative Medicine David T Scadden
Career-Development Lunch Sessions D. Gary Gilliland, Daniel J. DeAngelo, David Avigan, Ellis J. Neufeld
August 24, 2012 21st Annual Short Course on Experimental Models of Human Cancer Group B Van Transportation to GRB Training Lab | Workshop: (Group B) Pathology, Tissue Trimming, and Necropsy Paul Doty
Pathology and histopathology of normal and neoplastic tissue: an overview Paul Doty
EGFR Pathways and Cancer Pasi A Janne
Modeling the Ras Pathway in Cancer Karen Cichowski
Mouse Cancer Models for Targeting PI 3-K Lewis Cantley
Personalized medicine Raju Kucherlapati
Tumor Angiogenesis And Microenvironment Rakesh K Jain
Zebrafish Models to Dissect Human Cancer Pathways Thomas A. Look
December 13, 2011 New Horizons in Cancer Research: Biology to Prevention to Therapy Welcome and Opening Remarks Judy Garber
Epigenetics of hormone dependence Myles Brown
October 2, 2011 31st Annual Oncology Nurses Symposium Early Palliative Care Constance Dahlin
June 20, 2011 Changing Landscape of the Cancer Genome (F3) Somatic Genome Alterations in Human Lung Cancer Matthew Meyerson
GBM Lynda Chin
Characterizing the Prostate Cancer Genome Levi A Garraway
Talk Title to be Determined Richard Wilson
Protein Interactome Marc Vidal
March 6, 2011 Stem Cells, Cancer and Metastasis (C4) Genes that Regulate Migration and Invasion Joan S Brugge
Molecular characterization of circulating tumor cells Daniel A Haber
Stem Cells in Normal Lung and Lung Cancer Carla Bender Kim
Roundtable: Cancer Stem Cells in Metastasis: Insights and Controversies Daniel A Haber
February 17, 2011 15th Annual International Congress on Hematologic Malignancies: Focus on Leukemias, Lymphomas, and Myeloma Primary Central Nervous System Lymphoma Tracy T Batchelor
Management of Autoimmune Issues in Chronic Lymphocytic Leukemia Jennifer R. Brown
Comment Jennifer R. Brown
CDK Inhibitors Noopur Raje
PI3K | Akt Pathway Inhibitors Jennifer R. Brown
BCR | Downstream Therapeutic Targets Jennifer R. Brown
Aggressive Lymphoid Malignancies (Acute Lymphoblastic Leukemia, Lymphoblastic Leukemia, Burkitt Lymphoma) Daniel J. DeAngelo
Outlook for Management of Bone Disease in Multiple Myeloma Noopur Raje
Multiple Myeloma Noopur Raje
Acute Myeloid Leukemia | Myelodysplastic Syndromes Daniel J. DeAngelo
January 22, 2010 Highlights of American Society of Hematology® Hematopoietic Stem Cell Transplantation Corey Cutler
November 6, 2009 Translating Scientific Advances Into Clinical Care for Cancer Lung Cancer Thomas J. Lynch
August 18, 2009 Inaugural Novel Vaccines: Adjuvants & Delivery Systems Agonists of Pattern Recognition Receptors, including TLRs and NLRs, as Vaccine Adjuvants: Current Practice and Translational Development Ofer Levy
DNA Vaccines for HIV-1 Dan H Barouch
August 10, 2009 Second Annual Trends in Cancer Diagnostics EGFR and Beyond: Evolution of a Molecular Classification and Treatment Strategy for Lung Cancer Neal Lindeman
February 5, 2009 ACI’s National Conference on Successful Strategies For Genetic AN D Molecular Diagnostic Testing SPONSORS 2:15 PM - 3:15 PM The role of Molecular diagnostic testing in managing patients with lung adenocarcinoma Neal Lindeman
How to build a successful molecular diagnostics laboratory Gyorgy Abel
October 12, 2008 15th North American Regional Meeting - International Society for the Study of Xenobiotics Resolvins and Protectins : Anti-inflammatory and Pro-resolving Actions of Omega-3 Fatty Acid-derived Mediators Matthew Spite
September 22, 2008 Genomics Tools Genome-Wide Profiling of the Estrogen Response in Breast Cancer Through a Cistrome Integrative Approach Mathieu Lupien
June 27, 2008 American Society of Clinical Oncology New Presentation Philip Kantoff
General Session IV: Gastrointestinal (Non-Colorectal) Cancer Peter C Enzinger
General Session VI: Breast Cancer – Metastatic Erica L Mayer
General Session VIII: Myeloma Kenneth C Anderson
Program Commitee Arthur T Skarin, Bruce E. Johnson
General Session XII: Patient and Survivor Care Janet L Abrahm
General Session IX: Leukemia David Avigan
May 30, 2008 ASCO Annual'08 Meeting breast cancer-- Adjuvant Chemotherapy of Breast Cancer: Do We Still Need Anthracyclines? Eric P. Winer
breast cancer-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14A) Judy E Garber
breast cancer-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14B) Judy E Garber
cancer genetics-- Molecular Pathways of Cancer Predisposition in Children, Adolescents, and Young Adults Lisa Diller
cancer genetics-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14A) Judy E Garber
cancer genetics-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14B) Judy E Garber
cancer prevention/epidemiology-- Molecular Pathways of Cancer Predisposition in Children, Adolescents, and Young Adults Lisa Diller
cancer prevention/epidemiology-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14A) Judy E Garber
cancer prevention/epidemiology-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14B) Judy E Garber
central nervous system tumors-- Managing the Medical Complications of Patients with Brain Tumors (CPO10A) Patrick Y. Wen
central nervous system tumors-- Managing the Medical Complications of Patients with Brain Tumors (CPO10B) Patrick Y. Wen
clinical trials-- Early Data: Presenting and Publishing Preliminary Results Donna S. Neuberg
ethics-- Early Data: Presenting and Publishing Preliminary Results Donna S. Neuberg
gastrointestinal (noncolorectal) cancer-- Gastrointestinal Stromal Tumor (GIST) Comes of Age: Current Management Using Molecular Pathology, Surgery, and Targeted Therapy George Daniel Demetri
geriatric oncology--Adjuvant Chemotherapy of Breast Cancer: Do We Still Need Anthracyclines? Eric P. Winer
lung cancer-- Targeted and Novel Agents in Small Cell Lung Cancer Bruce E. Johnson
melanoma/skin cancers-- Melanoma in Children, Adolescents, and Young Adults David E Fisher
patient and survivor care-- Managing the Medical Complications of Patients with Brain Tumors (CPO10A) Patrick Y. Wen
patient and survivor care-- New Models for Survivorship Care Programs (M15) Lawrence N. Shulman
patient and survivor care-- Treatment Approaches and Functional Outcomes in Pediatric Sarcomas Mark Gebhardt
patient and survivor care-- Managing the Medical Complications of Patients with Brain Tumors (CPO10B) Patrick Y. Wen
pediatric cancer-- Molecular Pathways of Cancer Predisposition in Children, Adolescents, and Young Adults Lisa Diller
pediatric cancer-- Challenges and Optimizing Outcomes in Adolescents and Young Adults with Cancer Karen H. Albritton
pediatric cancer-- Treatment Approaches and Functional Outcomes in Pediatric Sarcomas Mark Gebhardt
pediatric cancer-- Melanoma in Children, Adolescents, and Young Adults David E Fisher
sarcoma/bone and soft tissue cancers-- Predicting and Targeting Drug Resistance to Tyrosine Kinase Inhibitors Jeffrey Adam Engelman
sarcoma/bone and soft tissue cancers-- Treatment Approaches and Functional Outcomes in Pediatric Sarcomas Mark Gebhardt
tumor biology-- Predicting and Targeting Drug Resistance to Tyrosine Kinase Inhibitors Jeffrey Adam Engelman
meet the professor sessions-- New Models for Survivorship Care Programs (M15) Lawrence N. Shulman
clinical problems in oncology-- Managing the Medical Complications of Patients with Brain Tumors (CPO10A) Patrick Y. Wen
clinical problems in oncology-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14A) Judy E Garber
clinical problems in oncology-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14B) Judy E Garber
clinical problems in oncology-- Managing the Medical Complications of Patients with Brain Tumors (CPO10B) Patrick Y. Wen
March 25, 2008 CANCER MOLECULAR MARKERS Therapeutic Potential of Targeting microRNAs in Chronic Myeloid Leukemia Tara M Love
Chairperson’s Remarks Tara M Love
October 11, 2007 Sixth International Colorectal Cancer Congress What’s New in Virtual Colonoscopy? Joseph Ferrucci
July 21, 2007 Hematopoietic Malignancies Stem cell interactions with the microenvironment David T Scadden
Identification and characterization leukemic stem cells in the Li Chai
Transcription factors and myeloid leukemia Daniel G Tenen
GATA-1, Trisomy 21, and M7 Leukemia Stuart Orkin
FBW7 Mutations in Leukemic Cells Mediate NOTCH Pathway Activation and Resistance to gamma-Secretase Inhibitors Thomas A. Look
Context depended role of LRF/Pokemon in Oncogenesis” Pier Paolo
The Fanconi Anemia/BRCA pathway and the DNA damage response Alan D Andrea
DNA Breaks, End-joining Pathways, Translocations, and Lymphoma Frederick Alt
The Role of JAK2 Activation in the Pathogenesis and Treatment of Myeloproliferative Disorders Ross Levine
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.